Canadian firm's implant controls glucose in diabetic pigs

07/12/2010 | Reuters

Diabetic pigs treated with Sernova's Cell Pouch System showed long-term normal glucose levels without experiencing adverse events, according to preclinical trials. The implantable device uses insulin-producing tissues, or islets, derived from the pancreas of the animals to enable the therapeutic cells to thrive and function in a natural environment.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT